Acrivon Therapeutics, Inc. Common Stock (ACRV) vs Inovio Pharmaceuticals, Inc. (INO)
A side-by-side comparison of Acrivon Therapeutics, Inc. Common Stock and Inovio Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACRV
Acrivon Therapeutics, Inc. Common Stock
$1.99HealthcareDelayed quote: Oct 6, 2026, 10:14 AM EDT
INO
Inovio Pharmaceuticals, Inc.
$1.14HealthcareDelayed quote: Oct 6, 2026, 10:15 AM EDT
Total return — ACRV vs INO
growth of $100 · dividends reinvested · last 4yACRV -88.1% (-41.3%/yr)INO -95.6% (-54.2%/yr)ACRV compounded faster over this window
ACRV INO
ACRV vs INO: by the numbers
- •ACRV is the larger company ($85M vs $79M market cap).
- •Both run net losses; ACRV's is the smaller (0.00% vs -130000.00% net margin).
Metrics side by side
Valuation
| Metric | ACRV | INO |
|---|---|---|
| P/B ratio | 0.98 | 18.02 |
Profitability
| Metric | ACRV | INO |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -132871.32% |
| Net margin | 0.00% | -130000.00% |
| ROE | -85.65% | -1542.57% |
| ROIC | -88.28% | -836.58% |
Growth (annualized)
| Metric | ACRV | INO |
|---|---|---|
| Total return CAGR (5Y) | N/A | -57.05% |
Go deeper
Dig into the metrics
Acrivon Therapeutics, Inc. Common Stock ROEInovio Pharmaceuticals ROEAcrivon Therapeutics, Inc. Common Stock operating marginInovio Pharmaceuticals operating marginAcrivon Therapeutics, Inc. Common Stock revenue growthInovio Pharmaceuticals revenue growthAcrivon Therapeutics, Inc. Common Stock free cash flowInovio Pharmaceuticals free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.